Overview
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, provides comprehensive products and services for pharmaceutical development, biomanufacturing, and analytical testing. The company offers single-use technologies, filtration systems, protein standards, quality control software, and consultative services to optimize complex life science workflows. With significant global capacity investments and innovative solutions like M-Trace sterility testing software, MilliporeSigma supports pharmaceutical manufacturers from research through manufacturing and quality assurance.
Frequently asked questions
- What biomanufacturing capabilities does MilliporeSigma offer?
- MilliporeSigma provides single-use technologies, closed processing systems, and process intensification solutions to minimize bioprocessing footprint. The company has invested over €250 million in single-use manufacturing capacity expansion at facilities in Molsheim, France, and Wuxi, China, and over €580 million in filtration manufacturing capacity globally.
- What quality control and regulatory compliance solutions are available?
- MilliporeSigma offers M-Trace Electronic Test Record Software, a digital solution for sterility testing that digitizes pharmaceutical microbial quality control workflows. The software provides real-time, comprehensive data traceability, automatically documents testing steps, and reduces deviations, false positives, and human error to support regulatory compliance.
- What analytical and research products does MilliporeSigma supply?
- MilliporeSigma offers Sigma-Aldrich full-length protein standards with high purity and isotopic incorporation, stable isotope-labeled internal standards, and high-quality calibrations for mass spectrometry proteomic assays. The company also provides consultative services to help customers optimize workflows in life science research, biomanufacturing, and analytical testing.